Are you ready to unlock new insights into your diagnostic processes?
We are thrilled to announce the latest release of Mastermind, featuring expanded content including ACMG secondary finding genes and a redesigned, sleek user interface making it more efficient for users to triage and report on actionable variants. The Product team at Genomenon has been working hard having in-depth client meetings, extensive brainstorming with in-house experts and intense design & development sessions. The result of these efforts is this next wave of updates with the release of Mastermind 3.1.
Here are some of the highlights you will see when logging into Mastermind -
- Sleek and redesigned interface reduces the number of clicks - Mastermind now has an updated design interface that enables users to navigate our wide and expansive literature content, increasing specificity and eliminating unnecessary clicks
- Expanded curated evidence including ACMG secondary findings expedites findings - we continue to increase our ever-growing body of curated content, including evidence citations for gene-disease relationships, and access to intrinsic metrics. While much of this expanded content is tailored for Professional users, Basic users will also have access to some of this new and updated information.
- Updated article display enhances information accessibility - The team has redesigned article display and navigation including displaying the type of evidence for Genomenon curated variants, whether “Functional” or “Clinical”, color coding , introducing article cards displaying title, abstract, author among other things - all aimed at enhancing accessibility and actionability.
Mastermind Release Notes: See the Latest Updates
The Genomenon Team
Genomenon is a leading genomic intelligence company dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer. Blending the power of AI with the genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development. The company’s solutions include software, data and curation and consulting services.
Learn more about Genomenon at genomenon.com and follow them on LinkedIn and Twitter.